BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24820095)

  • 1. Treatment of osteoporosis in older adults.
    Gosch M; Kammerlander C; Nicholas JA
    Panminerva Med; 2014 Jun; 56(2):133-43. PubMed ID: 24820095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacologic treatment of osteoporosis--2011].
    Lakatos P
    Orv Hetil; 2011 Aug; 152(33):1320-6. PubMed ID: 21824859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in the treatment of osteoporosis.
    Eriksen EF; Halse J; Moen MH
    Acta Obstet Gynecol Scand; 2013 Jun; 92(6):620-36. PubMed ID: 22646526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgeons save bones: an algorithm for orthopedic surgeons managing secondary fracture prevention.
    Gosch M; Kammerlander C; Roth T; Doshi HK; Gasser RW; Blauth M
    Arch Orthop Trauma Surg; 2013 Aug; 133(8):1101-8. PubMed ID: 23681470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
    Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
    Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic options in osteoporosis.
    Dominguez LJ; Scalisi R; Barbagallo M
    Acta Biomed; 2010; 81 Suppl 1():55-65. PubMed ID: 20518192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.
    Josse R; Khan A; Ngui D; Shapiro M
    Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis.
    Krege JH; Wan X
    Bone; 2012 Jan; 50(1):161-4. PubMed ID: 22036910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the management of osteoporosis in the aging female population.
    Amin U; McPartland A; O'Sullivan M; Silke C
    Womens Health (Lond); 2023; 19():17455057231176655. PubMed ID: 37218715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis.
    Marcus R; Wang O; Satterwhite J; Mitlak B
    J Bone Miner Res; 2003 Jan; 18(1):18-23. PubMed ID: 12510801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal osteoporosis.
    Diab DL; Watts NB
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):501-9. PubMed ID: 24150190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current options for the management of postmenopausal osteoporosis.
    Lecart MP; Reginster JY
    Expert Opin Pharmacother; 2011 Nov; 12(16):2533-52. PubMed ID: 21916810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of women at risk for fracture and intervention with fast-acting therapies.
    Derman R
    Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab.
    Tarantino U; Celi M; Feola M; Liuni FM; Resmini G; Iolascon G
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S65-9. PubMed ID: 24046047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab.
    Capozzi A; Lello S; Pontecorvi A
    Gynecol Endocrinol; 2014 Jun; 30(6):403-8. PubMed ID: 24592987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis in men.
    Gielen E; Vanderschueren D; Callewaert F; Boonen S
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):321-35. PubMed ID: 21397201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.